Suchergebnisse - "Kakavand, Hessam"

PubPharm (14)

1

Optimizing antithrombotic therapy in patients with coexisting cardiovascular and gastrointestinal disease

enthalten in: Nature reviews. Cardiology | 2024

von Talasaz, A. | Sadeghipour, P. | Ortega-Paz, L. | +33

2

Atorvastatin versus Placebo in ICU Patients with COVID-19 : Ninety-day Results of the INSPIRATION-S Trial

enthalten in: Thrombosis and haemostasis | 2023

von Talasaz, A. | Sadeghipour, P. | Bakhshandeh, H. | +64

3

Evaluating the role of intravenous pentoxifylline administration on primary percutaneous coronary intervention success rate in patients with ST-elevation myocardial infarction (PENTOS-PCI)

enthalten in: Naunyn-Schmiedeberg's archives of pharmacology | 2023

von Kakavand, H. | Saadatagah, S. | Naderian, M. | +9

4

A stepwise approach to prescribing novel lipid-lowering medications

enthalten in: Journal of clinical lipidology | 2022

von Kakavand, H. | Aghakouchakzadeh, M. | Shahi, A. | +4

5

Preprocedural Colchicine in Patients With Acute ST-elevation Myocardial Infarction Undergoing Percutaneous Coronary Intervention : A Randomized Controlled Trial (PodCAST-PCI)

enthalten in: Journal of cardiovascular pharmacology | 2022

von Hosseini, S. | Talasaz, A. | Alidoosti, M. | +9

CommentIn: J Cardiovasc Pharmacol. 2022 Oct 01;80(4):499. - PMID 35921633

6

Atorvastatin versus placebo in patients with covid-19 in intensive care : randomized controlled trial

enthalten in: BMJ (Clinical research ed.) | 2022

von INSPIRATION-S Investigators | Bikdeli, B. | Talasaz, A. | +64

7

Intermediate-Dose versus Standard-Dose Prophylactic Anticoagulation in Patients with COVID-19 Admitted to the Intensive Care Unit : 90-Day Results from the INSPIRATION Randomized Trial

enthalten in: Thrombosis and haemostasis | 2022

von Bikdeli, B. | Talasaz, A. | Rashidi, F. | +57

8

Use of novel antithrombotic agents for COVID-19 : Systematic summary of ongoing randomized controlled trials

enthalten in: Journal of thrombosis and haemostasis : JTH | 2021

von Talasaz, A. | Sadeghipour, P. | Aghakouchakzadeh, M. | +13

9

Investigating Lipid-Modulating Agents for Prevention or Treatment of COVID-19 : JACC State-of-the-Art Review

enthalten in: Journal of the American College of Cardiology | 2021

von Talasaz, A. | Sadeghipour, P. | Aghakouchakzadeh, M. | +20

UpdateOf: medRxiv. 2021 May 04;:. - PMID 33972948

10

Effect of Intermediate-Dose vs Standard-Dose Prophylactic Anticoagulation on Thrombotic Events, Extracorporeal Membrane Oxygenation Treatment, or Mortality Among Patients With COVID-19 Admitted to the Intensive Care Unit : The INSPIRATION Randomized Clinical Trial

enthalten in: JAMA | 2021

von INSPIRATION Investigators | Sadeghipour, P. | Talasaz, A. | +77

CommentIn: JAMA. 2021 Apr 27;325(16):1613-1615. - PMID 33734290